Antonio Arellano Moral

At Telara Pharma, we develop innovative therapies based on cilastatin, a drug with a solid safety record and a powerful neuroprotective effect on the retina. Our goal is to transform glaucoma and diabetic retinopathy retreatments through a strategy that targets retinal neurodegeneration and inflammation—two key processes that current medicine does not address. Unlike therapies focused solely on reducing intraocular pressure (IOP), our ophthalmic drops directly protect retinal ganglion cells, preserving vision and quality of life.

At Tensor Medical, we work to help clinical experts to improve care for patients suffering Multiple Sclerosis. We develop unique and automated machine intelligence tools that reduce the error associated with visual reading of magnetic resonance images of patients, offering unprecedented sensitivity and specificity detecting new appearing lesions. We dream to improve patients’ health and quality of life by developing novel tools to obtain the most robust and precise imaging biomarkers that will allow to predict the future stages of the disease and optimize the treatment decisions for each patient. We are humans, we build tools for humans.

Lumiris strives to help intended parents in their in vitro fertilization journey by identifying the most competent embryo to increase the likelihood of a successful pregnancy. We bring forth a novel hyperspectral technology to assist professionals in evaluating embryos, ultimately reducing subjectivity. This non-invasive technology delivers detailed color-coded images for analyzing embryo metabolism, surpassing the standard black and white images of embryo morphology

A Biomedical Company Improving Drug Accumulation In Cancer Cells

Rediseñando la cadena alimentaria 🌎 🐛 En Insectius, criamos e investigamos al gusano de la harina (Tenebrio molitor) para ofrecer soluciones más sostenibles y de calidad ante las nuevas necesidades de nuestro mundo. Producimos más ingredientes con menos recursos apoyándonos en la tecnología.

Somos el puente entre tu empresa y el sector del Body Art. Lo que tengas en mente, podemos hacerlo. You name it, we do it.

At Telara Pharma, we develop innovative therapies based on cilastatin, a drug with a solid safety record and a powerful neuroprotective effect on the retina. Our goal is to transform glaucoma and diabetic retinopathy retreatments through a strategy that targets retinal neurodegeneration and inflammation—two key processes that current medicine does not address. Unlike therapies focused solely on reducing intraocular pressure (IOP), our ophthalmic drops directly protect retinal ganglion cells, preserving vision and quality of life.

At Tensor Medical, we work to help clinical experts to improve care for patients suffering Multiple Sclerosis. We develop unique and automated machine intelligence tools that reduce the error associated with visual reading of magnetic resonance images of patients, offering unprecedented sensitivity and specificity detecting new appearing lesions. We dream to improve patients’ health and quality of life by developing novel tools to obtain the most robust and precise imaging biomarkers that will allow to predict the future stages of the disease and optimize the treatment decisions for each patient. We are humans, we build tools for humans.

Lumiris strives to help intended parents in their in vitro fertilization journey by identifying the most competent embryo to increase the likelihood of a successful pregnancy. We bring forth a novel hyperspectral technology to assist professionals in evaluating embryos, ultimately reducing subjectivity. This non-invasive technology delivers detailed color-coded images for analyzing embryo metabolism, surpassing the standard black and white images of embryo morphology

A Biomedical Company Improving Drug Accumulation In Cancer Cells

Rediseñando la cadena alimentaria 🌎 🐛 En Insectius, criamos e investigamos al gusano de la harina (Tenebrio molitor) para ofrecer soluciones más sostenibles y de calidad ante las nuevas necesidades de nuestro mundo. Producimos más ingredientes con menos recursos apoyándonos en la tecnología.